Microvast Holdings (MVST) Appoints Yeelong Tan Balladon to its Board

Microvast Holdings, Inc. (NASDAQ: MVST) today announced that Yeelong Tan Balladon has been appointed to the Board of Directors of the Company (the “Board”), effective as of July 1, 2022. As a Class III director, Ms. Balladon will serve on the Board until the Company’s annual meeting of shareholders in 2024. She has also been appointed as a member of the Company’s nominating and corporate governance and audit committees and as chair of the Company’s compensation committee.

“We are excited to welcome Yeelong to our Board and we look forward to her guidance as Microvast continues to execute its growth strategy and scale its operations globally. We look forward to her future contributions to shareholder value creation,” said Mr. Yang Wu, Microvast’s Chairman and Chief Executive Officer.

“I’m delighted to join Microvast’s Board at this critical inflection point in the Company’s electrification journey,” said Ms. Balladon. “Microvast has industry leading technologies and I look forward to working with the Board and the management team to help the Company exceed its goals.”

Ms. Balladon has served as the lead independent trustee of the board of the Ashmore Funds since 2010 and as lead independent trustee since 2014. The Ashmore Funds is a registered US mutual funds complex dedicated to investing in emerging markets. Ms. Balladon also served as a non-executive director of Pacnet Limited from 2008-2015 and Jasper Investments from 2011 to 2015. Ms. Balladon was an associate and subsequently a partner at Freshfields Bruckhaus Deringer, an international law firm, from 1982 to 1988 and 1994 to 2009. She retired from the partnership in 2009. Ms. Balladon holds an LL.B. from the National University of Singapore and is legally professionally qualified in Singapore, England & Wales and the New York Bar.

You May Also Be Interested In

• Virtus Investment Partners names Jack Boyce to its board
• Hertz Global amends voting agreement with CK Amarillo after lawsuit
• James Hardie sells Fermacell unit to Holcim for €840 million